Evidence map›Paper›PMID 25754199›Full record

ArticleInfection and immunity2015

Superantigenic Yersinia pseudotuberculosis induces the expression of granzymes and perforin by CD4+ T cells.

Agathe Goubard, Caroline Loïez, Jun Abe, Caroline Fichel, Stéphanie Herwegh, Christelle Faveeuw, Rémi Porte, Delphine Cayet, Florent Sebbane, Sylvie Penet and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Agathe GoubardUniversité Lille Nord de France, INSERM U1019, CNRS UMR 8204, and Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France.
Caroline LoïezLaboratoire de Bactériologie Hygiène, Institut de Microbiologie, Centre de Biologie Pathologie, CHRU Lille, Lille, France.
Jun AbeNational Research Institute for Child Health and Development, Tokyo, Japan.
Caroline FichelUniversité Lille Nord de France, INSERM U1019, CNRS UMR 8204, and Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France.
Stéphanie HerweghLaboratoire de Bactériologie Hygiène, Institut de Microbiologie, Centre de Biologie Pathologie, CHRU Lille, Lille, France.
Christelle FaveeuwUniversité Lille Nord de France, INSERM U1019, CNRS UMR 8204, and Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France.
Rémi PorteUniversité Lille Nord de France, INSERM U1019, CNRS UMR 8204, and Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France.
Delphine CayetUniversité Lille Nord de France, INSERM U1019, CNRS UMR 8204, and Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France.
Florent SebbaneUniversité Lille Nord de France, INSERM U1019, CNRS UMR 8204, and Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France.
Sylvie PenetLaboratoire de Biochimie, Centre de Biologie Pathologie, CHRU Lille, Lille, France.
Benoit FolignéUniversité Lille Nord de France, INSERM U1019, CNRS UMR 8204, and Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France.
Pierre DesreumauxINSERM U995, Lille, France.
Hirohisa SaitoNational Research Institute for Child Health and Development, Tokyo, Japan.
Jean-Claude SirardUniversité Lille Nord de France, INSERM U1019, CNRS UMR 8204, and Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France.
Michel SimonetUniversité Lille Nord de France, INSERM U1019, CNRS UMR 8204, and Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France Laboratoire de Bactériologie Hygiène, Institut de Microbiologie, Centre de Biologie Pathologie, CHRU Lille, Lille, France.
Christophe CarnoyUniversité Lille Nord de France, INSERM U1019, CNRS UMR 8204, and Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France christophe.carnoy@univ-lille2.fr.
Inserm · FRCentre National de la Recherche Scientifique · FRInstitut de Biologie de Lille · FRInstitut Pasteur de Lille · FRNational Center For Child Health and Development · JPCenter for Infection and Immunity of Lille · FRUniversité Lille Nord de France · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial superantigens (SAgs) are immunostimulatory toxins that induce acute diseases mainly through the massive release of inflammatory cytokines. Yersinia pseudotuberculosis is the only Gram-negative bacterium known to produce a SAg (Y. pseudotuberculosis-derived mitogen [YPM]). This SAg binds major histocompatibility complex class II molecules on antigen-presenting cells and T cell receptors (TcR) bearing the variable region Vβ3, Vβ9, Vβ13.1, or Vβ13.2 (in humans) and Vβ7 or Vβ8 (in mice). We have previously shown that YPM exacerbates the virulence of Y. pseudotuberculosis in mice. With a view to understanding the mechanism of YPM's toxicity, we compared the immune response in BALB/c mice infected with a YPM-producing Y. pseudotuberculosis or the corresponding isogenic, SAg-deficient mutant. Five days after infection, we observed strong CD4(+) Vβ7(+) T cell expansion and marked interleukin-4 (IL-4) production in mice inoculated with SAg-producing Y. pseudotuberculosis. These phenomena were correlated with the activation of ypm gene transcription in liver and spleen. A transcriptomic analysis revealed that the presence of YPM also increased expression of granzyme and perforin genes in the host's liver and spleen. This expression was attributed to a CD4(+) T cell subset, rather than to natural killer T (NKT) cells that display a TcR with a Vβ region that is potentially recognized by YPM. Increased production of cytotoxic molecules was correlated with hepatotoxicity, as demonstrated by an increase in plasma alanine aminotransferase activity. Our results demonstrate that YPM activates a potentially hepatotoxic CD4(+) T cell population.

Indexed as

AnimalsCD4-Positive T-LymphocytesGene Expression ProfilingGranzymesLiverMice, Inbred BALB CPore Forming Cytotoxic ProteinsSpleenSuperantigensT-Lymphocyte SubsetsYersinia pseudotuberculosisGranzymesperforin, mousePore Forming Cytotoxic ProteinsSuperantigens

Identifiers

PMID25754199
PMCPMC4399040
OpenAlexW2131656634

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.